-Heinz Feldmann Researcher Activity Profile

Research Author Detailed Information 

Heinz Feldmann Publication Rate By Year

Heinz Feldmann has published 6 paper(s) in 1949, 6 paper(s) in 1953, 1 paper(s) in 1958, 1 paper(s) in 1982, 2 paper(s) in 2006, 39 paper(s) in 2007, 3 paper(s) in 2008, for a total of 58 research publications in total.

Heinz H Feldmann Author Information

LAST NAME: feldmann

FIRST NAME: Heinz

INITIALS: h

AFFILIATION:

Papers

Heinz Feldmann's Publication Record

1. Ebola virus: unravelling pathogenesis to combat a deadly disease. Year Published: 2006
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St., Winnipeg, MB R3E 3R2, Canada.
2. Assembly and budding of Ebolavirus. Year Published: 2006
Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
3. Rapid molecular strategy for filovirus detection and characterization. Year Published: 2007
Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
4. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. Year Published: 2007
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA.
5. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Year Published: 2007
Columbia University, New York, New York 10032, USA.
6. Dedication: jim orzechowski (1944-2003) and Michael kiley (1942-2004). Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, R3E 3R2, Canada. Heinz_Feldmann@phac-aspc.gc.ca.
7. Filoviruses: recent advances and future challenges. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada. tgeisbert@bu.edu.
8. Outbreaks of filovirus hemorrhagic Fever: time to refocus on the patient. Year Published: 2007
Tulane School of Public Health and Tropical Medicine, New Orleans, LA, 70112, USA. dbausch@tulane.edu.
9. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of ebola virus infection. Year Published: 2007
Bundeswehr Institute of Microbiology, Munich, Germany. andreaslu@gmx.de.
10. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, R3E 3R2, Canada. Ute_Stroeher@phac-aspc.gc.ca.
11. In vitro and in vivo characterization of recombinant ebola viruses expressing enhanced green fluorescent protein. Year Published: 2007
Department of Special Pathogens, International Research Center for Infectious Diseases, University of Tokyo, Tokyo, Japan. Hideki_Ebihara@phac-aspc.gc.ca.
12. Breakdown of Paraendothelial Barrier Function during Marburg Virus Infection Is Associated with Early Tyrosine Phosphorylation of Platelet Endothelial Cell Adhesion Molecule-1. Year Published: 2007
Institute of Physiology, Technical University, Dresden, D-01307, Germany. Hans.Schnittler@mailbox.TU-Dresden.de.
13. Epitopes required for antibody-dependent enhancement of ebola virus infection. Year Published: 2007
Department of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, 060-0818, Japan. atakada@czc.hokudai.ac.jp.
14. In Vitro Evaluation of Antisense RNA Efficacy against Filovirus Infection, by Use of Reverse Genetics. Year Published: 2007
National Laboratory for Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, R3E 3R2, Canada. Heinz_Feldmann@phac-aspc.gc.ca.
15. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of ebola virus hemorrhagic Fever. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canad, Manitoba, R3E 3R2, Canada. Steven_jones@phac-aspc.gc.ca.
16. Mucosal Delivery of Adenovirus-Based Vaccine Protects against Ebola Virus Infection in Mice. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, R3E 3R2, Canada. gary_kobinger@phac-aspc.gc.ca.
17. Ebola sGP--the first viral glycoprotein shown to be C-mannosylated. Year Published: 2007
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3.
18. Genomic evolution of the proteasome system among hemiascomycetous yeasts. Year Published: 2007
Institute for Bioinformatics, GSF, Ingolstaedter Landstr. 1, D-85764, Neuherberg, Germany.
19. Filoviruses: recent advances and future challenges. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada.
20. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. Year Published: 2007
Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA. dbausch@tulane.edu
21. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. Year Published: 2007
Bundeswehr Institute of Microbiology, Munich, Germany. andreaslu@gmx.de
22. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada R3E 3R2. Ute_Stroeher@phac-aspc.gc.ca
23. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. Year Published: 2007
Department of Special Pathogens, International Research Center for Infectious Diseases, University of Tokyo, Tokyo, Japan. Hideki_Ebihara@phac-aspc.gc.ca
24. Breakdown of paraendothelial barrier function during Marburg virus infection is associated with early tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1. Year Published: 2007
Institute of Physiology, Technical University, Dresden, D-01307, Germany.
25. Epitopes required for antibody-dependent enhancement of Ebola virus infection. Year Published: 2007
Department of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo 060-0818, Japan. atakada@czc.hokudai.ac.jp
26. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. Year Published: 2007
National Laboratory for Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada.
27. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Canada. Steven_jones@phac-aspc.gc.ca
28. Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Canada.
29. Ebola sGP--the first viral glycoprotein shown to be C-mannosylated. Year Published: 2007
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3.
30. [Not Available.] Year Published: 1949
31. [Not Available.] Year Published: 1949
32. [Not Available.] Year Published: 1949
33. [Not Available.] Year Published: 1949
34. [Dysprosody consecutive to cranio-cerebral injury; tonal disorders of speech.] Year Published: 1953
35. [Motor aphasia, right tactile asymboly, and sensory-motor Jacksonian disorders following cranio-cerebral trauma.] Year Published: 1953
36. [Fatal evolution in a case of recurrence of an old cerebral abscess after 12 years; anatomical and clinical studies.] Year Published: 1953
37. [Parinaud syndrome in 2 cases of lethargic encephalitis.] Year Published: 1953
38. [Persistent right homonymous hemianopsia following a hornet sting.] Year Published: 1953
39. [Sensorimotor syndrome in a case of traumatic encephalopathy. Quantitative study of the sensory and motor disorders.] Year Published: 1953
40. Generation of biologically contained Ebola viruses. Year Published: 2008
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
41. [Not Available.] Year Published: 1949
42. [Not Available.] Year Published: 1949
43. Genomic evolution of the proteasome system among hemiascomycetous yeasts. Year Published: 2007
Institute for Bioinformatics, GSF, Ingolstaedter Landstr. 1, D-85764, Neuherberg, Germany.
44. [Studies on the phenomenon of auricular adaptation.] Year Published: 1958
45. Filoviruses: recent advances and future challenges. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada.
46. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. Year Published: 2007
Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA. dbausch@tulane.edu
47. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. Year Published: 2007
Bundeswehr Institute of Microbiology, Munich, Germany. andreaslu@gmx.de
48. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada R3E 3R2. Ute_Stroeher@phac-aspc.gc.ca
49. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. Year Published: 2007
Department of Special Pathogens, International Research Center for Infectious Diseases, University of Tokyo, Tokyo, Japan. Hideki_Ebihara@phac-aspc.gc.ca
50. Breakdown of paraendothelial barrier function during Marburg virus infection is associated with early tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1. Year Published: 2007
Institute of Physiology, Technical University, Dresden, D-01307, Germany.
51. Epitopes required for antibody-dependent enhancement of Ebola virus infection. Year Published: 2007
Department of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo 060-0818, Japan. atakada@czc.hokudai.ac.jp
52. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. Year Published: 2007
National Laboratory for Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada.
53. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Canada. Steven_jones@phac-aspc.gc.ca
54. Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. Year Published: 2007
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Canada.
55. Person-to-person transmission of Nipah virus in a Bangladeshi community. Year Published: 2008
Program on Infectious Diseases and Vaccine Sciences, ICDDR,B, Dhaka, Bangladesh. egurley@icddrb.org
56. [Emergencies in general medicine (24). Sudden deafness] Year Published: 1982
57. Genomic evolution of the proteasome system among hemiascomycetous yeasts. Year Published: 2007
Institute for Bioinformatics, GSF, Ingolstaedter Landstr. 1, D-85764, Neuherberg, Germany.
58. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Year Published: 2008
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Tokyo 108-8639, Japan.